CTIS.eu › Cities › Poland › Rzeszow
Rzeszow
Poland
324 total trials
127 recruiting
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2022-500795-62-00
4
2024-03-25
Eosinophilic gastritis
2022-501703-27-00
5
2023-07-05
Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
2023-504595-26-00
4
2023-05-22
Non-Small Cell Lung Cancer
2023-507031-38-00
5
2023-01-09
Severe viral lung infections
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
2023-506548-18-00
10
2022-11-10
Dermatitis atopic
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
2023-509694-22-00
5
2022-01-26
Ulcerative Colitis (UC)
2025-522567-15-00
5
2026-04-28
Plaque Psoriasis
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
2025-522705-37-00
4
2026-04-21
HIDRADENITIS SUPPURATIVA
2025-521456-35-00
4
2026-04-13
Mild to moderate asthma
2025-522583-32-00
5
2026-04-13
Cold-Induced Urticaria and Symptomatic Dermographism
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
2025-521036-11-00
5
2026-03-23
Immune system disseases
2025-521035-37-00
5
2026-03-02
Immune system diseases
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)
2025-520771-59-00
4
2026-02-03
Atopic Dermatitis
2025-522370-36-00
4
2026-02-02
Moderate to Severe Atopic Dermatitis
Showing 49–72 of 324 trials